Indication
Adult: PO
Auditory, vestibular and visual disorders of ischaemic aetiology; Cerebrovascular insufficiency; Functional rehabilitation after cerebrovascular accidents
Per tab contains almitrine 30 mg and raubasine 10 mg:
1 tab twice daily.
Administration
Not to be used concurrently with other almitrine-containing preparations.
Potentially Fatal: MAOIs.
Adult Dose
Pregnancy. Long term treatment may result in numbness, prickling or formication effects in the lower limbs which may, in rare cases, lead to treatment withdrawal.
Renal Dose
Almitrine and raubasine work together to increase the amount of oxygen brought to the brain and neurosensory tissue, by increasing the oxygen content of arterial blood.
Precaution
Cerebrovascular insufficiency, Functional rehabilitation after cerebrovascular accidents, Auditory, Vestibular and visual disorders of ischaemic aetiology, Stroke
Pregnancy Category Note
Mild GI disorders, sleep disturbances, palpitations, anxiety, dizziness.
Rarely, wt loss, peripheral neuropathy with abnormal sensations in the lower limbs.
Interaction
Concurrent usage with MAOIs.